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We have developed highly eﬃcient antimicrobial nanocarriers for berberine (BRB) based on shellac
nanoparticles (NPs) which were surface-functionalised with a surface active polymer, Poloxamer 407
(P407), and the cationic surfactant octadecyltrimethylammonium bromide (ODTAB). These shellac
nanocarriers were produced in a two-step process which involves: (i) a pH change from aqueous
ammonium shellac solution using P407 as a steric stabilizer in the presence of berberine chloride, and (ii)
addition of ODTAB to yield shellac nanocarriers of cationic surface. We determined the BRB
encapsulation eﬃciency and release proﬁles from such nanocarriers. We explored the antimicrobial
action of these nanocarriers at diﬀerent stages of their preparation which allowed us gain better
understanding how they work, ﬁne tune their design and reveal the impact of the nanoparticle coatings
on to its antimicrobial eﬀect. The antimicrobial action of BRB loaded within such shellac NPs with
cationic surface functionality was examined on three diﬀerent microorganisms, C. reinhardtii,
S. cerevisiae and E. coli and compared with the eﬀect of free BRB as well as non-coated BRB-loaded
nanocarriers at the same BRB concentrations. We found that the cationic surface coating of the shellac
NPs strongly ampliﬁed the eﬃciency of the encapsulated BRB across all tested microorganisms. The
eﬀect was attributed to the increased attraction between the ODTAB-coated BRB-loaded NPs and the
anionic surface of the cell walls which delivers locally high BRB concentration. This nanotechnological
approach could lead to more eﬀective antimicrobial and disinfecting agents, dental formulations for
plaque control, wound dressings, antialgal/antibiofouling formulations and antifungal agents.Introduction
Nanocarrier systems have been widely developed in the phar-
maceutical industry due to their ability to control the release of
drugs for eﬃcient delivery.1 Recently, nanocarriers formulated
from biodegradable materials have attracted much attention
following concerns about the post-use fate of the nanocarrier
formulations.2,3 Environmentally biodegradable NPs from
renewable natural materials such as lignin, cellulose and
shellac could have a wide range of industrial and pharmaceu-
tical applications. Frangville et al.4 developed biodegradable
lignin nanoparticles which showed no measurable toxicity
against proxy organisms such as yeast and microalgae.
Recently, these were applied in a delivery system based on
Ag+-loaded lignin NPs which were coated with a cationic poly-
electrolyte.5,6 Al-Awady et al.7 demonstrated that the nano-
toxicity of polyelectrolyte-coated NPs alternates with the surface
charge where the particles with a cationic outer layer are much, University of Hull, Hull, HU67RX, UK.
)1482 466410; Tel: +44 (0)1482 465660
tion (ESI) available. See DOI:
Chemistry 2018more toxic than the ones with an outer layer of anionic
polyelectrolyte.
Berberine (BRB) is an isoquinoline alkaloid (Fig. 1B) which
can be found in the roots, rhizome, and stem barks of a number
of commonly therapeutic plant species such as Berberis vulgaris,
Hydrastis canadensis, Coptis chinensis, Arcangelisia ava,
B. aquifolium and B. aristata.8 A range of studies indicate that
BRB possesses many signicant pharmacological and biological
activities, including antimicrobial, anti-helminthic, anti-
inammatory, and anti-oxidative eﬀects.9–11 It has been sug-
gested that BRB may also have an eﬀect on other diseases such
as diabetes, arrhythmia, hypertension, gastrointestinal
diseases,12 and that it is a potential chemotherapeutic agent.13
Berberine delivery systems based on liposomes, solid lipid
nanoparticles and nano-emulsions have been recently
explored.14 Several approaches have been used to prepare BRB-
loaded liposomes, such as the active loading method, the thin
lm evaporation method and a combination of the active
loading and thin lm evaporation methods.14,15 Solid lipid
nanoparticles (SLNs) loaded with BRB have been prepared from
biodegradable solid lipids using a mixture of lipid materials,
showing good stability with a mean size of 77 nm and a BRB
loading percent of 4.2%. BRB–SLNs at high dose (100 mg kg1)Nanoscale Advances
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View Article Onlineshowed more potent eﬀects when compared to an equivalent
dose of BRB.16Using a high-pressure homogenizationmethod,17
BRB was loaded within SLNs using glyceryl monostearate with
a drug entrapment eﬃciency of 70 and loading drug ratio of
2.85.
BRB-loaded SLNs showed signicant inhibition in vitro for
breast cancer MCF-7 cells, HepG 2, and A549 cancer cells.18
Khemani et al.19 loaded BRB onto polylactide glycolic acid
nanoparticles using biodegradable poly(D,L-lactide-co-glycolide)
with ratio of a 75 : 25 by single emulsion as well as multiple
emulsion solvent evaporation techniques with BRB encapsula-
tion of 65%. Another study reported BRB-loaded O-hexadecyl-
dextran NPs which were evaluated for their cyto-protective eﬃ-
cacy in high glucose stressed primary hepatocytes and these
showedmuch higher eﬃciency than free BRB in inhibiting high
glucose induced oxidative stress, mitochondrial depolarization
and downstream events of apoptotic cell death.20 Al-Awady
et al.21 developed antimicrobial particles based on BRB encap-
sulated in surface-functionalised nanogels.
Shellac is the rened product of the natural material Lac
secreted by the small parasitic insect Kerria lacca on diﬀerent
host trees in South Eastern Asia. It has numerous applications
in agriculture, food products and enteric coatings for tablets,22
lacquers,23,24 dental baseplates,25,26 dental varnishes27,28 coating
and matrix material,23,29,30 additive in foods and cosmetic
products, encapsulating agent in pharmaceuticals,31–33 as well
as a moisture barrier coating for fruits and vegetables.34,35Fig. 1 (A) Schematics of the two step process for preparation of shellac
stabilisation with Poloxamer 407 (P407) and doping with the cationic sur
structures of the constituting materials for preparation of antimicrobial
decyltrimethylammonium bromide (ODTAB), shellac and berberine chlo
Nanoscale AdvancesShellac is a complex mixture of polar and non-polar compo-
nents consisting of polyhydroxyl acids, lactones and anhy-
drides,36–38 it has a pKa of 6.9 to 7.5 and it is acid resistant,39
being practically insoluble in acidic to neutral aqueous medium
(pH < 7).31,40,41 Colloidal shellac dispersions have been reported
in literature for coating purposes, precipitated from alcoholic
shellac solution in distilled water.42 Colloidal shellac with
particle size 150–300 nm was formulated by Patel et al.43 for
silibinin encapsulation by using an anti-solvent method and
xanthan gum as stabilizer. Kraisit et al.44 used chitosan as
stabilizer to prepare shellac suspensions with size range 100–
300 nm for encapsulation of bovine serum albumin. Krause and
Mu¨ller45 reported preparation of an aqueous shellac dispersion
using high pressure homogenisation technique, although the
obtained particle size was rather large (5 mm). We present
a more comprehensive comparison of BRB nanocarriers in the
ESI (Table S1†).
In the present study, we combine some of these ideas to
develop an ultra-eﬃcient BRB nanocarrier for antimicrobial
applications based on biocompatible surface functionalised
shellac NPs. Fig. 1A explains the steps of the encapsulation of
BRB into the shellac nanocarriers and their surface function-
alisation. The retention of the BRB in the core of the nanogel is
based on hydrophobic and electrostatic interactions within the
shellac matrix of the nanocarrier particles. Here we report dual-
functionalised nanocarriers for BRB based on sterically stabi-
lised shellac NPs with a cationic surface functionality whichnanocarriers for berberine with cationic surface functionality by steric
factant octadecyltrimethylammonium bromide (ODTAB). (B) Molecular
shellac nanocarriers for berberine (BRB): Poloxamer 407 (P407), octa-
ride.
This journal is © The Royal Society of Chemistry 2018
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View Article Onlinehave a long shelf life and are also able to strongly adhere to
microbial cell walls.
This was done by using a surface active tri-block-copolymer,
Poloxamer 407 (see Fig. 1), which sterically stabilised the
formed shellac NPs suspension and enabled us to develop very
small shellac NPs loaded with BRB in one preparation step.
However, achieving cationic surface functionality of the nano-
carrier required doping of the pre-formed sterically stabilised
shellac NPs suspension with an ultra-low concentration of
a water-insoluble cationic surfactant (ODTAB) – see Fig. 1. The
choice of ODTAB was justied as it allows direct adsorption on
the shellac NPs surface while the already formed P407 layer in
the rst step remains intact. This strategy proved very success-
ful, as the carrier maintained its steric stability while being
surface charge-reversed by secondary coating with ODTAB. We
studied the antibacterial, anti-fungal and antialgal action of the
BRB-loaded shellac NPs compared with free BRB on three proxy
microorganisms, C. reinhardtii, S. cerevisiae and E. coli, respec-
tively. We also studied the BRB release kinetics and the boost of
its antimicrobial action before and aer surface functionalising
of the shellac NPs with ODTAB. We show that this strategy can
strongly amplify the antimicrobial action of BRB compared to
solutions with an equivalent concentration of free BRB or the
non-loaded nanocarrier.
Materials and methods
Materials
Shellac was used in a soluble form as the ammonium salt at pH
> 7, the alkaline solution was a gi from (Stroever Schellack
Bremen, Germany) and is commercially available as SSB
Aqua Gold™ (solid content 25%). Poloxamer 407 (puried),
berberine chloride (98%), and 30,60-diacetyle uorescein (FDA),
were obtained from Sigma-Aldrich ltd. UK. Octadecyl-
trimethylammonium bromide (ODTAB) was supplied by Fluka
Chemika, UK. The BacTiter-Glo Microbial Cell Viability Assay
was purchased from Promega, UK. Chlamydomonas reinhardtii
(cc-124 strain) was kindly provided by Flickinger group from
North Carolina University, USA. This microalgae culture was
grown in Tris-Acetate-Phosphate (TAP) culture medium and
incubated at a temperature of 30 C. The C. reinhardtii culture
media consisted of TAP salts (NH4Cl; MgSO4$7H2O and CaCl2-
$2H2O), phosphate buﬀer solution (PBS) and Hutner's trace
elements solution (EDTA disodium salt, ZnSO4$7H2O, H3BO3,
MnCl2$4H2O, CoCl2$6H2O, CuSO4$5H2O, FeSO4$7H2O, (NH4)6-
Mo7O24$4H2O, all purchased from Sigma-Aldrich, UK). The
microalgae batch was grown in the TAP media at pH 7 while
being illuminated for 72 hours with a white luminescent lamp
with a light intensity of 60 W m2 under constant stirring with
a magnetic stirrer.12,13,46
The stock cultures of C. reinhardtii were with typical
concentration 4  105 cells per mL determined by cell counter
(Nexcelom Cellometer Auto X4) and the E. coli bacterial culture
stock was with approximately 5  107 cells per mL. Saccharo-
myces cerevisiae (Baker's yeast), was purchased from Sigma-
Aldrich. It was cultured by hydrating 10 mg of lyophilized
yeast cells in 10 mL Milli-Q water. Then 1 mL of this hydratedThis journal is © The Royal Society of Chemistry 2018suspension was added to 100 mL of autoclaved YPD culture
media47 consisting of peptone (Sigma Aldrich, UK), D-glucose,
(Fisher Scientic, UK), and yeast extract, (Oxoid ltd, UK.), then
incubated at 30 C for 24–48 hours. Escherichia coli, sourced
from Thermosher (InvitrogenMAX Eﬃciency™DH10B™) was
kindly provided for our antibacterial tests by Prof Rotchell's
group at the University of Hull, UK. The cells were cultured in
autoclaved Luria–Bertani medium (LB medium)47,48 prepared by
dissolving 0.5 g yeast extract, 0.5 g sodium chloride (Sigma
Aldrich), and 1 g tryptone (Oxido ltd), in 100 mL water. Fluo-
rescein diacetate (FDA, 98%) for cell viability assays was
supplied from Sigma Aldrich, UK. Deionised water puried by
reverse osmosis and ion exchange from a Milli-Q water system
(Millipore, UK) was used in all our studies. Its surface tension
was 71.9 mN m1 at 25 C, with measured resistivity less than
18 MU cm1.
Preparation of shellac NPs and loading with BRB
Shellac NPs were prepared by mixing 0.25 w/v% of ammonium
shellac salt and BRB solution at pH 8 with diﬀerent concen-
trations of P407 and then lowering the solution pH to 5 by
adding drop-wise 0.01 M HCl with agitation. Diﬀerent concen-
trations of BRB were used in a mixture of shellac and P407 with
a constant ratio of 0.25 wt% : 0.2 wt%, respectively.
Cationic surface functionalization of the BRB-loaded shellac
NPs
In order to promote their adhesion to the negatively charged
microbial cell walls, the shellac NPs surface charge was reversed
from negative (P407-stabilised shellac NPs loaded with BRB) to
positive by additional coating with the cationic surfactant
ODTAB. Typically, 0.03 wt% of BRB loaded in 0.25 wt% shellac
NP was coated with varied concentrations of ODTAB (delivered
to the shellac NP suspension by drop-wise addition from 3%
ODTAB in ethanol at constant stirring).
Shellac NPs size, zeta-potential and morphology
characterisation
The particle size distribution and zeta-potential of the shellac
NPs with and without BRB were measured by the dynamic light
scattering (DLS) technique using a zeta sizer Nano ZL (Malvern
Instrument Ltd, UK). All measurements were carried out in
triplicates. Morphological examination of the nanoparticles was
performed by transmission electron microscopy (TEM) (Joel
2010, Japan), a few drops of the sample were placed on carbon-
coated copper grids and negatively stained with 1% aqueous
uranyl acetate. Once air dried, the sample was imaged with
a Gatan Ultrascan 4000 digital camera attached to the Jeol 2010
TEM running at 200 kV.
Fourier transform infrared (FTIR) and UV-vis spectroscopy
study
FTIR spectroscopy (Thermo Scientic Nicolet 380 FT-IR, Hemel
Hempstead, UK) was used to characterise the shellac NPs and
BRB-loaded shellac NPs. This technique was also used toNanoscale Advances
Nanoscale Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
7 
N
ov
em
be
r 2
01
8.
 D
ow
nl
oa
de
d 
on
 1
1/
30
/2
01
8 
9:
39
:1
5 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlineconrm the adsorption of P407 on shellac NPs surface and the
intercalation between the BRB and the shellac molecules. In
order to conrm the loading percentage of BRB within the
shellac NPs a UV-vis spectrophotometry technique was used. A
sample of BRB-loaded shellac NPs was dissolved in alkaline
solution (pH 8) and the spectrum was recorded between 220–
700 nm using spectrophotometer (model Bio Lambda 10, USA).
Same spectra were recorded at the same range for shellac, P407
and free BRB.
Encapsulation eﬃciency and BRB loading contents in shellac
NPs
The encapsulation eﬃciency and the drug loaded content was
indirectly calculated by measuring the absorbance of the non-
encapsulated drugs. The non-encapsulated BRB solution was
ltered using a 20 nm syringe lter and the absorbance of this
ltered BRB solution was measured at 422 nm using UV-vis
spectrophotometer (model Bio Lambda 10, USA). Calibration
curve of BRB was made by measuring the absorbance of a series
of standard BRB solutions. The BRB loading contents and
encapsulation eﬃciency were calculated as shown below49
Encapsulation efficiency ð%Þ ¼
½total drug unencapsulated drug
½total drug  100
Drug loading content ð%Þ ¼
½total drugunencapsulated drug  100
½ðtotal drugunencapsulated drugÞþshellacþpoloxamer amount
In vitro BRB release kinetics from shellac NPs
The dialysis method was used to determine the in vitro BRB
release prole from the shellac NPs. 50 mL of the sample con-
taining of BRB-loaded shellac NPs were dialyzed. A dialysis bag
of 12–14 K MWCO with pore diameter 2.5 nm was immersed in
a 500 mL buﬀer phosphate solutions (for pH 5.5 and 7.4). The
bag was stirred gently with an orbital shaker at 37 C temper-
ature and 100 rpm. At specic time intervals, 2 mL of the dial-
ysis solution was taken and analysed by measuring the UV-vis
absorbance from 200 to 700 nm. The measurements were taken
at 15, 30, 60, 120, 180, 240, 300, 360 and 1440 minutes. All
release experiments were carried out in triplicates. The
percentage of cumulative drug release was calculated using the
equation shown below50
% in vitro BRB release ¼ Mreleased
Mtotal
 100;
where Mreleased is the amount of BRB released from the shellac
NPs at time t and Mtotal is the amount of BRB loaded.
Antimicrobial activity of the non-coated BRB-loaded shellac
NPs
To study their antimicrobial action, diﬀerent concentrations of
the non-coated BRB-loaded shellac NPs and ODTAB-coatedNanoscale AdvancesBRB-loaded shellac NPs stock suspensions were mixed with
xed aliquots of the microbial cells for various incubation
times. The cells were removed from their original growth media
and transferred in Milli-Q water. Blank shellac NPs without BRB
(as a negative control) and free BRB aqueous solution (positive
control) was incubated as with equivalent cell samples for the
same durations. The cell viability of C. reinhardtii and yeast was
measured using a cell counter aer incubating 1 mL of the
treated cells (washed from the shellac NPs formulation), with 10
mL of 0.1% FDA in acetone for 10 minutes and washing with
Milli-Q water by centrifugation. The viability of E. coli was
measured aer incubating the cells with the BRB-loaded shellac
NPs. 100 mL of the treated E. coli suspension was washed and
mixed with 100 mL of BacTiter-Glo™ cell viability reagent in
white opaque 96-well microplate and shaken for 5 minutes. The
bioluminescence intensity was then measured using a BMG
LABTECH instrument (FLUOstar Omega, Germany).Protocol for SEM imaging of the treated cell samples
The cells were washed with Milli-Q water 3 times to remove the
residual NPs by centrifugation at 3000 rpm for 3 minutes. The cell
sample was deposited on dry Aclar™ sheets or poly-lysine coated
glass coverslips, xed with 2.5 w/v% glutaraldehyde for 2 hours,
followed by washing with cacodylate buﬀer. The cells were post
xed for 1 hour in 1 wt% osmium tetroxide, washed with a caco-
dylate buﬀer, then rinsed with serial ethanol–water solutions
starting from 50% ethanol moving up to absolute ethanol, then
dried using a critical point dryer. Finally, the samples were coated
with carbon (10 nm) in an evaporator and imaged using scan-
ning electron microscope SEM (ZEISS EVO 60 EP-SEM, Germany).Results and discussion
Preparation and characterisation of BRB-loaded shellac NPs
The stable shellac nanoparticles were prepared based on a steric
repulsion mechanism using P407, a surface active polymer, as
stabilizer and the adjustment of the pH from 8 to 5. P407 is
a non-ionic co-polymer made up of poly(ethylene oxide) (PEO)–
poly(propylene oxide) (PPO) poly(ethylene oxide) (PEO) (see
Fig. 1B), which has been widely used in pharmaceutical
formulations as a surfactant, solubilizing agent, emulsifying
and dispersing agent.51 The P407 polymer performed very well
in sterically stabilizing the shellac NPs due to its amphiphilic
nature and the fact that the hydrophobic PPO block adsorbs on
the hydrophobic shellac surface attaching two PEO chains (per
P407 molecule) on the particle surface (see Fig. 1A). The steric
repulsion between these chains on the surface of the shellac
NPs leads to their stabilisation. Fig. 2A and B and show the
particle size distribution and the zeta potential of shellac NPs
formed by mixing 0.25 wt% of shellac with 0.2 wt% P407 at pH
5. The results show narrow particle size and zeta-potential
distributions with an average shellac particle size of 66 
5 nm and zeta-potential of 18  8 mV. Fig. 2E shows the
dependence of the average particle size and zeta potential on
the pH of the solution. One can see that the particle size is
insensitive to pH as the shellac particles are sterically stabilised,This journal is © The Royal Society of Chemistry 2018
Fig. 2 (A) Particle size and (B) zeta-potential distribution of shellac nanoparticles was obtained by mixing a ratio of 0.25 : 0.2 wt% of ammonium
shellac: P407 from pH 8 to pH 5 in Milli-Q water. (C) TEM and (D) SEM image of ODTAB-coated BRB-loaded shellac NPs; (E) the shellac NPs
average diameter and zeta-potential as a function of the pH of the media. (F) The eﬀect of the loading BRB concentration on the size of shellac
NPs produced using 0.25 wt% ammonium shellac at pH 5 and 0.2 wt% P407. (G) The average size and zeta potential of shellac NPs obtained by
adding 0.25 wt% ammonium shellac solution (pH 8) to solutions of diﬀerent P407 concentrations in Milli-Q water at pH 5.
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View Article Onlinewhile the zeta-potential is negative due to the dissociation of the
COOH groups of the shellac constituents. Note that here no
ODTAB was used to coat these shellac NPs. We used SEM and
TEM imaging to explore the morphological characteristic of
shellac NPs, BRB-loaded shellac NPs, and ODTAB-coated BRB-
loaded shellac NPs, as can be seen in Fig. 2D and E, respec-
tively. The images show that the shape of the shellac NPs is
spherical with size less than 50 nm for uncoated particles and
less than 100 nm for the coated NPs. We have also used the TEM
images of the shellac NPs to measure the particle size distri-
bution and present the results in the ESI le, as shown in
Fig. S2,†which also agrees with Zetasizer measurements at pH 5
(see Fig. 2A). Fig. 2F shows that the size of the shellac NPs
increased with increasing of BRB loading concentration. Note
that the zeta-potential of the BRB-loaded shellac NPs decreased
slightly as the BRB loading concentration increased due to the
electrostatic attraction between the carboxylic groups of the
shellac constituents and the BRB cations.
Fig. 2G shows the average size and the zeta potential of the
shellac NPs at diﬀerent concentrations of P407. The particle size
remains fairly constant above 0.2 wt% P407 while the zeta-
potential decreases slightly due to the oﬀsetting of the surface
by the PEO chains of the attached P407 layers.FTIR and UV-vis spectroscopy studies
The infrared absorption spectra of shellac, P407, BRB, shellac
nanoparticles, and BRB-loaded shellac NPs are represented inThis journal is © The Royal Society of Chemistry 2018Fig. 3A, the spectrum of shellac (blue line) shows a main broad
peak at 3319 cm1 which relates to the absorption of the O–H
stretching vibration band, and a peak at 1707 cm1 represent-
ing the carbonyl stretching vibration band (C]O) along with
a C–O stretching band appearing at 1247 cm1.39,52 The P407
spectrum (black line) shows a principal absorption peaks at
2878 cm1 for C–H aliphatic stretching and at 1342 cm1 for the
absorption of OH (in-plane O–H bend), another principal peak
can be observed at 1097 cm1 which can be assigned to the C–O
stretch.53 Apart from some slight shis in peaks the IR spectrum
of the shellac nanoparticles (brown line) shows no diﬀerence to
P407 or shellac spectrum.
Some of the P407 peaks were merged with shellac peaks as
there is no chemical reaction between shellac and P407, the
attraction is an adsorption of the hydrophobic part of P407 on
shellac surface, and O–H stretching band still exist at
3392 cm1, while the carbonyl stretching vibration (C]O) and
C–O stretching bands appears at 1711 cm1 and 1241 cm1
respectively. The infrared spectrum of free BRB (red line) is
characterised by a principal peak at 1602 cm1 relating to the
–C]N– quaternary iminium ion, and a peak at 1504 cm1
(C]C stretching vibration of aromatic ring).54 The intensity of
these peaks declined when BRB was loaded into shellac nano-
particles andmost BRB peaks overlap with the shellac NPs bands,
this proves the reaction between BRB and shellac, the broad band
for O–H stretching seen for shellac still exists although it has
shied slightly as can be seen in Fig. 3A (green line). The BRB
content within the nanoparticles was also proved by using UV-visNanoscale Advances
Fig. 3 (A) Fourier Transform Infra-Red (FTIR) spectra of BRB–NPs, free BRB, P407, shellac ammonium salt (free shellac), and Shellac NPs; (B) UV-
vis absorption spectrum of BRB, free shellac, non-coated BRB-loaded shellac NPs and P407; (C) the encapsulation eﬃciency percentage of
diﬀerent concentrations of BRB-loaded shellac NPs at pH 5, and (D) the percentage of in vitro BRB release as a function of time at diﬀerent pH.
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View Article Onlinespectroscopy technique. Fig. 3B shows the UV-vis absorption
spectra of shellac, P407, free BRB and BRB-loaded shellac NPs.
The shellac spectrum (black line) shows random peaks at 220–
300 nm due to its diﬀerent carboxylic acid components without
a signicant maximum wavelength, while the free BRB (blue line)
has four absorption peaks, one which was in the visible area with
a wavelength of 422 nm and three peaks in the UV region with
wavelengths at 350 nm, 265 nm and 230 nm, respectively. These
spectra show that there is no spectral interference between the
absorbance of shellac, BRB and P407 (which has no signicant
peak between 220–700 nm, red line). The green line is the
absorbance spectrum for the BRB-loaded shellac NPs (BRB NPs)
where it can be clearly seen that two peaks appear at 422 and
350 nm belonging to BRB with no specic peaks around wave-
lengths 220 and 300 nm due to shellac absorption, this provides
a clear evidence that the cationic BRB is conjugated with the
anionic carboxyl groups of the shellac constituents.
BRB encapsulation eﬃciency and release kinetics from shellac
NPs
We experimented with diﬀerent BRB concentrations and
BRB : shellac ratios and we report here only the optimal
combination which yielded the best encapsulation eﬃciency.
The BRB encapsulation eﬃciency within the NPs was measured
at pH 5. It was found that the highest encapsulated amount of
BRB within shellac nanoparticles was about 60% at the
following composition, 0.03 wt% : 0.25 wt% : 0.2 wt% of
BRB : shellac : P407 respectively, as shown in Fig. 3C. The in
vitro release prole measurement of BRB from shellac NPs wasNanoscale Advancescarried out in PBS at pH 5.5 and 7.4. Fig. 3D shows the BRB
release prole which was higher at acidic pH 5.5, and reached
100% aer 8 hours, while at pH 7.4 the maximum released BRB
was about 75% aer 8 hours.
The cytotoxicity eﬀect of non-loaded shellac NPs
In order to determine whether the loading of BRB within shellac
nanoparticles could enhance the antibacterial activity of BRB,
the cytotoxic eﬀect for each component of the nanocarrier, was
studied on representative microalgae, yeast and bacterial cells.
The cytotoxic assay of shellac NPs was determined by incuba-
tion of the cells with shellac NPs suspensions of diﬀerent
shellac concentrations produced by serial dilutions of more
concentrated stock. The cells were removed from the culture
media to avoid any interaction between the shellac NPs and the
media components. Fig. 4 shows the cytotoxic eﬀects of shellac
NPs without BRB on C. reinhardtii, S. cerevisiae and E. coli,
respectively. As it can be seen from Fig. 4A, there is a small eﬀect
of shellac NPs on the algal cells at relatively high concentration
due to the antibacterial properties of P407, which was used as
a stabilizer. It has been previously reported that P407 might
create a adsorption layer on the microbial cell surface,55–57 so
the combination between P407 and the shellac NPs may play
a synergistic antimicrobial role within this nanocarrier
design. The shellac NPs, however, showed no pronounced
eﬀect when incubated with yeast and E. coli for 6 hours, as
demonstrated in Fig. 4B and C. One possible explanation for
the lack of eﬀect on yeast is that its cells have much a thicker
cell wall which mitigates the eﬀect of P407 at theseThis journal is © The Royal Society of Chemistry 2018
Fig. 4 The eﬀect of the P407 stabilised non-loaded shellac NPs on the viability of (A) C. reinhardtii, (B) S. cerevisiae and (C) E. coli cells incubated
with diﬀerent concentrations of shellac NPs (made from ﬁxed ratio of 0.25 wt% ammonium shellac and 0.2 wt% P407) at diﬀerent incubation
times. The ratios on the x-axis show the actual concentrations of both shellac and P407. No BRBwas used in these experiments. Here the shellac
NP were stabilised by P407 but not coated with ODTAB.
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View Article Onlineconcentrations. For all cell types studied, at lower concen-
tration the shellac NPs are benign over the duration of the
experiment (4 hours).Antimicrobial activity of BRB-loaded shellac NPs
We compared the antimicrobial activity of free BRB and BRB-
loaded shellac NPs on the same microbial cultures, C. rein-
hardtii, S. cerevisiae and E. coli, in order to determine whether
the loading of BRB within the shellac NPs could enhance its
antimicrobial activity. The purpose of encapsulating BRB
within shellac NPs was to increase the antimicrobial action of
BRB. This was achieved due to the increased surface area of
the nanocarrier, resulting in the need for less antimicrobial,
thus reducing the potential side eﬀects of the drug. Further-
more the BRB encapsulation increases the BRB local concen-
tration which leads to enhance stability and the bioavailability
in medical formulations increasing its eﬃcacy.58–62 Fig. 5
shows the cell viability of the C. reinhardtii as a function of the
concentration of free BRB. The experiment shows that aer
incubation for 15 minutes with 0.01 wt% and 0.05 wt% free
BRB, the viability of the algal cells is reduced instantly from
91% (for the control) to 18% and 11%, respectively. Aer 2
hours of incubation, the algal cells viability rapidly declined
from 90% (for the control) to be 3% at 0.01 wt% of free BRB,
while at 0.05 wt% all algal cells were killed. The cell viability
kept reducing as the incubation time increased, and aer 6
hours most cells died at free BRB concentrations of 0.007 wt%
or higher. These ndings are consistent with the literature
reports63 that BRB is an eﬀective antimicrobial agent at
reasonably low concentrations over suﬃciently long period of
time. Correspondingly, we studied the cytotoxicity of non-
coated BRB-loaded shellac NPs on the same algal cells. As it
was shown previously, that BRB can be eﬃciently encapsulated
within shellac NPs up to 60% with the release reaching up to
100% of the total amount of BRB at pH 5.5 aer 6 hours.
Fig. 5B shows the eﬀect of diﬀerent concentrations of BRB-This journal is © The Royal Society of Chemistry 2018loaded shellac NPs on the algal cell viability at room temper-
ature up to 6 hours. However, aer 15 minutes incubation, the
algal cells appeared to be not signicantly aﬀected by the BRB-
loaded shellac NPs as the viability was reduced slightly to 77%
at 0.01 wt% BRB–Shellac NPs in comparison with the control
which was 92%. The latter represents the viability of algal cells
alone in a solution of pH 5.5. Aer 6 hours of incubation the
viability of the cell decreased slightly, at 0.007 wt% and
0.01 wt% of BRB-loaded in shellac NPs, the cell viability
decreased to be 6% and 1.5% respectively. The corresponding
SEM images of the treated algal cells revealed a good evidence
for the eﬀect of free BRB and BRB encapsulated within shellac
NPs on the cells aer 4 hours of incubation. Fig. 5E and F
shows that the morphology of the algal cells has changed from
relatively smooth and round (Fig. 5C and D) to irregular
shapes aer incubating with 0.01 wt% free BRB and most algal
cells lose their agella compared with the control sample
(Fig. 5C and D). Interestingly, the algal cells incubated with
BRB-loaded shellac NPs for the same period and overall BRB
concentration (Fig. 5G and H), were not visibly aﬀected. One
possible explanation for the reduced performance of the BRB-
loaded in shellac NPs is that the nanocarrier particles loaded
with BRB still maintain their negative surface charge which
caused a electrostatic repulsion between them and the nega-
tively charged algal cell membrane. This reduces the overall
eﬀect of BRB as most of it remains encapsulated in the
nanocarrier without direct contact with the cells.
We also performed similar experiments with S. cerevisiae for
comparison of the eﬀect of free BRB and non-coated BRB-
loaded shellac NPs at the same overall BRB concentration.
The results are presented in Fig. 6A for free BRB and Fig. 6B for
BRB-loaded shellac NPs. One can see that the free BRB has no
signicant anti-yeast eﬀect over the studied range of BRB
concentrations. However, a much stronger eﬀect is observed
with BRB-loaded shellac NPs. One can possible attribute this to
the build-up of an adsorption layer of P407-stabilised BRB-
loaded shellac NPs which brings some fraction of them inNanoscale Advances
Fig. 5 The viability of C. reinhardtii upon incubation at pH 5.5 with aqueous solutions of diﬀerent concentrations of (A) free BRB and (B) BRB-
loaded shellac NPs (non-coated with ODTAB) at room temperature up to 6 hours incubation time at pH 5.5. (C)–(H) SEM images of C. reinhardtii
whereby (C) and (D) represent the control sample of the microalgae cells. (E) and (F) C. reinhardtii incubated with 0.01 wt% free BRB after 4 hours
incubation, (G) and (H) C. reinhardtii incubated with 0.01 wt% BRB-loaded in shellac NPs up to 4 hours. Note that the free BRB is more eﬀective
anti-algal agent than the non-coated shellac NPs with the same concentration of shellac NP-loaded BRB.
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View Article Onlineclose proximity of the yeast cells. This is partially supported by
the SEM images of the cells (Fig. 6G and H) where we can
identify a limited number of adhering BRB nanocarriers. In the
case of free BRB, the yeast cells morphology remains visibly
unaﬀected (Fig. 6E and F) compared with the control sample
(Fig. 6C and D). The same type comparison between the anti-
bacterial eﬀect of free BRB and BRB-loaded shellac NPs on E.
coli reveal a result similar to that of the algal cells, as described
earlier. Fig. 7A shows that free BRB has a slightly higher anti-
bacterial action than the equivalent amount of BRB-loaded in
shellac NPs (Fig. 7B). The SEM images of the treated E. coli show
more signicant change in the cells walls morphology for cells
treated with free BRB (Fig. 7E and F) compared with the control
(Fig. 7C and D) and these treated with BRB-loaded shellac NPs
(Fig. 7G and H). The latter show very few BRB nanocarriers
remaining on the bacterial cell walls due to the electrostatic
repulsion between them.Antimicrobial eﬀect of free ODTAB and ODTAB-coated non-
loaded shellac NPs
We studied the cytotoxicity of the ODTAB and the non-loaded
shellac NPs which have been coated with ODTAB (without
BRB), on algae, yeast, and bacteria in order to gain better
understanding of its contribution towards the antimicrobial
eﬃciency of the coated nanocarrier. Fig. 8A–C show the eﬀect of
free ODTAB delivered directly to the cell cultures of the algae,
yeast and the bacteria aer 15 minutes of incubation. Note that
ODTAB alone has very high toxicity at moderate concentrations.Nanoscale AdvancesODTAB is a cationic surfactant but it is practically insoluble
in water at room temperature. Since it was delivered in the cell
suspension from 1 wt% ODTAB in ethanol solution, one can
expect that ODTAB is in particulate form (precipitates) which act
as cationic particles and has potentially the ability to disturb the
cell membranes, hence its relatively high toxicity. However, at
low concentrations ODTAB has limited eﬀect on the cell viability.
Fig. 8D–F show the antimicrobial eﬀect of shellac NPs coated
with ODTAB on the same microbial cell cultures. It can be seen
that the ODTAB-coated nanocarriers (non-loaded) have signi-
cantly lower toxicity compared with the equivalent amount of
free ODTAB alone. In our nanocarrier design we have chosen the
lowest concentration of ODTAB (0.001 wt%) with which to coat
the shellac NPs as this does not incur high additional toxicity of
the nanocarrier particles themselves. This allowed us to compare
the eﬀect of the BRB loading on the nanocarrier antimicrobial
action. Fig. 9 shows the SEM images of the three types of
microbial cells incubated with non-loaded ODTAB-coated
shellac NPs. One can see that there is a signicant accumula-
tion of nanocarrier particles on the surface of the cell walls for C.
reinhardtii (Fig. 9A and B) and E. coli (Fig. 9E and F). For the yeast
cells (Fig. 9C and D), once can clearly see changes on the yeast
cell wall morphology, but no nanocarrier particles have
remained attached aer the SEM sample preparation (cf. with
Fig. 6G and H where the nanocarrier is not charged positively).
One possible explanation for the diﬀerent result for yeast is that
the cell wall is not suﬃciently charged for electrostatic adhesion
to retain the particles during the SEM sample preparation.This journal is © The Royal Society of Chemistry 2018
Fig. 6 The viability of S. cerevisiae upon incubation at pH 5.5 with aqueous solutions of diﬀerent concentrations of (A) free BRB and (B) BRB-
loaded shellac NPs (non-coated with ODTAB) at room temperature up to 6 hours incubation time at pH 5.5. (C)–(H) SEM images of S. cerevisiae
whereby (C) and (D) represent the control sample. (E) and (F) S. cerevisiae cells incubated with 0.01 wt% free BRB after 4 hours incubation, (G) and
(H) S. cerevisiae incubated with 0.01 wt% BRB-loaded in shellac NPs up to 4 hours. Note that the free BRB is less eﬀective anti-yeast agent than
the non-coated shellac NPs with the same concentration of shellac NP-loaded BRB.
Fig. 7 The viability of E. coli upon incubation at pH 5.5 with aqueous solutions of diﬀerent concentrations of (A) free BRB and (B) BRB-loaded
shellac NPs (non-coated with ODTAB) at room temperature up to 6 hours incubation time at pH 5.5. (C)–(H) SEM images of E. coli whereby (C)
and (D) represent the control sample of the microalgae cells. (E) and (F) E. coli incubated with 0.01 wt% free BRB after 4 hours incubation, (G) and
(H) E. coli incubated with 0.01 wt% BRB-loaded in shellac NPs up to 4 hours. Note that the free BRB is more eﬀective antibacterial agent than the
non-coated shellac NPs with the same concentration of shellac NP-loaded BRB.
This journal is © The Royal Society of Chemistry 2018 Nanoscale Advances
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View Article Online
Fig. 8 The cytotoxic eﬀect of solutions of diﬀerent ODTAB concentrations on (A) C. reinhardtii, (B) S. cerevisiae and (C) E. coli for several
diﬀerent incubation times at room temperature. The cytotoxic eﬀect of non-loaded ODTAB-coated shellac NPs of diﬀerent concentrations on
(D) C. reinhardtii, (E) S. cerevisiae and (F) E. coli for several diﬀerent incubation times at room temperature. The shellac NPs were not loaded with
BRB. The ratio of shellac : ODTAB in the NPs is ﬁxed to 5 : 1. The x-axis shows the variation of the shellac and ODTAB concentrations for these
experiments.
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View Article OnlineAntimicrobial eﬀect of ODTAB-coated BRB-loaded shellac NPs
Fig. 10A shows the antimicrobial activity of diﬀerent concen-
trations of BRB loaded in shellac NPs coated with ODTAB on C.
reinhardtii at diﬀerent incubation times. Here the nanocarrier
has cationic surface functionality due to the ODTAB coating and
is loaded with encapsulated BRB. Note the diﬀerence with the
non-coated BRB-loaded shellac NPs in Fig. 6B. This comparison
shows that aer changing the surface charge of the nanocarrier
from negative (Fig. 6B) to positive (Fig. 10A) using ODTAB
coating, the BRB-loaded shellac NPs became much more
eﬀective antimicrobial agents. Aer only 15 minutes of incu-
bation, all algal cells were killed at concentrations from
0.003 wt% to 0.01 wt% encapsulated BRB, and the algal cell
viability was sharply reduced to 50% at 0.00005 wt% of encap-
sulated BRB. Aer 2 hours, the cell viability decreased signi-
cantly about 75% at 0.001 wt% of BRB loaded in ODTAB-coated
shellac NPs. Fig. 10B shows the comparison among the anti-
microbial activities of 0.0001 wt% encapsulated BRB,
0.0001 wt% free BRB, 0.0005 wt% shellac NPs coated with
0.0001 wt% ODTAB (no BRB), 0.0001 wt% BRB encapsulated in
shellac NPs coated with 0.0001 wt% ODTAB, and 0.0001 wt%
pure ODTAB. As it can be seen that there was an increase in the
antimicrobial activity for the encapsulated BRB aer being
coated with ODTAB in comparison with the free BRB. The likely
reason behind the increase in the antimicrobial activity of BRB
aer coating of the nanocarrier with ODTAB is the positive
surface charge which attracts the NPs to the negatively algal cell
walls and allow high concentration of BRB to be locallyNanoscale Advancesdelivered on the cell, although the overall BRB concentration in
the formulation is extremely low. These ndings are supported
by the SEM images in Fig. 10D–F of C. reinhardtii cells aer
incubating for 2 hours with 0.005 wt% of BRB loaded shellac
NPs coated with 0.005 wt% ODTAB which indicate that the
positively charged surface ODTAB-coated BRB-loaded shellac
NPs are indeed attracted to the algal cell membrane, thus
increasing the delivered amount of BRB directly on the cell
membrane.
Our earlier test results presented Fig. 7 showed that free BRB
and encapsulated BRB within non-coated shellac NPs do not
have signicant cytotoxic eﬀect on S. cerevisiae due to its extra-
thick yeast cell wall (200 nm) which is hard to penetrate by BRB
even at relatively high concentrations. In Fig. 11A we show the
antimicrobial activity of ODTAB-coated BRB-loaded shellac NPs
upon incubation as a function of the encapsulated BRB
concentration. Aer 15 minutes exposure time, the cell viability
severely decreased from 99% at control to 25%, 17% and 11% at
0.005, 0.007, and 0.01 wt% of BRB loaded in shellac NPs coated
with 0.005, 0.007, and 0.01 wt% ODTAB, respectively. Aer 4
hours all cells died at 0.007 wt% and 0.01 wt% BRB loaded
shellac NPs coated with ODTAB. Fig. 11B gives the comparison
among the antimicrobial activities of 0.001 wt% BRB–shellac
NPs, 0.001 wt% free BRB, 0.005 wt% shellac NPs coated with
0.001 wt% ODTAB, 0.001 wt% BRB encapsulated in shellac NPs
coated with 0.001 wt% ODTAB, and 0.001 wt% free ODTAB. It
can be seen that aer coating of the BRB-loaded shellac NPs
with ODTAB, the activity against yeast also increased, although
less than for algal cells. Free BRB solution and non-coated BRB-This journal is © The Royal Society of Chemistry 2018
Fig. 9 SEM images of microbial cells with 0.025 wt% ODTAB-coated 0.125 wt% shellac NPs after 4 hours incubation at pH 5.5. (A) and (B) C.
reinhardtii, (C) and (D) S. cerevisiae and (E) and (F) E. coli after 4 hours incubation at pH 5.5. The shellac NPs were not loaded with BRB.
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View Article Onlineloaded shellac NPs did not show any antimicrobial eﬀect on
yeast while the incubation with ODTAB-coated BRB-loaded
shellac NPs caused a noticeable damage to yeast cell walls,
which was also supported by the SEM images of the treated
yeast cells presented in Fig. 11–F, compared with the control
(Fig. 11C).
The antibacterial activity of BRB-loaded shellac NPs coated
with ODTAB on E. coli cells was examined by incubating various
concentration of ODTAB-coated BRB-loaded shellac NPs as
shown in Fig. 12A. There is a marked increase of the antibac-
terial activity at concentrations of encapsulated BRB from
0.001 wt% to 0.01 wt% aer 15 minutes of incubation, where
the E. coli cell viability declined from 40  105 RLU (for the
control) to (15, 13 and 11)  105 RLU at 0.005, 0.007 and
0.01 wt% overall concentration of BRB loaded in shellac NPsThis journal is © The Royal Society of Chemistry 2018coated with 0.008, 0.01 and 0.017 wt% ODTAB, respectively.
Aer 1 hour the cell viability decreased strongly from 39  105
RLU to (4.3, 3.6, and 3.2) x105 RLU at 0.005, 0.007 and 0.01 wt%
overall concentration of encapsulated BRB coated with 0.008,
0.01 and 0.017 wt% ODTAB respectively. We found that the cell
viability decreased extremely sharply aer 2 hours of incubation
in this treatment and most cells died at concentration higher
than 0.005 wt% of encapsulated BRB in ODTAB-coated shellac
NPs. Fig. 12(B) shows a comparison between the eﬀects of free
BRB, non-coated and ODTAB-coated BRB-loaded shellac NPs
upon incubation with E. coli as well as the antibacterial activity
of ODTAB-coated non-loaded shellac NPs (no BRB) and free
ODTAB. Similarly to the case of algal and yeast cells, the non-
coated BRB-loaded shellac NPs showed lower activity against
E. coli than the free BRB aer 2 hours of incubation time,Nanoscale Advances
Fig. 10 (A) The viability of C. reinhardtii upon incubation at pH 5.5 with aqueous solutions of diﬀerent concentrations of BRB encapsulated in
ODTAB-coated BRB-loaded shellac NPs. The solutions were prepared from 0.05 wt% BRB (shellac) NPs stock solution coated with 0.05 wt%
ODTAB. (B) The C. reinhardtii viability upon incubation with 0.0001 wt% encapsulated BRB in shellac NPs, 0.0001 wt% free BRB, 0.0005 wt%
shellac NPs coated with 0.0001 wt% ODTAB, 0.0001 wt% BRB–NPs coated with 0.0001 wt%ODTAB, and 0.0001 wt% pure ODTAB at pH 5.5 and
at room temperature. (C)–(F) SEM images of C. reinhardtii whereby (C) represent the control sample. (D)–(F) C. reinhardtii incubated with
0.005 wt% BRB loaded shellac NPs coated with 0.005 wt% ODTAB after 2 hours at room temperature.
Fig. 11 (A) The viability of S. cerevisiae upon incubation at pH 5.5 with diﬀerent amounts of BRB-loaded shellac NPs coated with ODTAB at room
temperature at diﬀerent incubation time. The solutions were prepared from 0.05 wt% BRB (shellac) NPs stock solution coated with 0.05 wt%
ODTAB. (B) The yeast cells viability upon incubationwith 0.001 wt% BRB–NPs, 0.001wt% free BRB, 0.005wt% shellac NPs coatedwith 0.001wt%
ODTAB, 0.001 wt% BRB–(shellac NPs) coated with 0.001 wt% ODTAB, and 0.001 wt% pure ODTAB. (C) SEM images of the control sample of S.
cerevisiae, (D)–(H) SEM images of S. cerevisiae incubated with 0.01 wt% BRB loaded in shellac NPs coated with 0.01 wt% ODTAB after 2 hours at
room temperature.
Nanoscale Advances This journal is © The Royal Society of Chemistry 2018
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Fig. 12 (A) The antimicrobial activity of diﬀerent concentrations of BRB-loaded shellac NPs coated with ODTAB against E. coli. These solutions
were prepared from 0.03 wt% BRB loaded shellac NPs coated with 0.05 wt% ODTAB as stock solution. (B) The relative luminescence unit
representing the E. coli viability upon incubation with 0.005 wt% BRB loaded in shellac NPs coated with 0.008 wt% ODTAB in regards to the
antimicrobial activity of free BRB and BRB-loaded shellac NPs and the cytotoxic eﬀect of pure ODTAB and ODTAB-coated shellac NPs. The
incubation was also achieved through incubating each concentration with a ﬁxed amount of E. coli at pH 5.5. (C)–(F) SEM images of E. coli
whereby (C) represent the control sample, (D) and (E) E. coli incubated with 0.01 wt% BRB-loaded in shellac NPs coated with 0.017 wt% ODTAB
(F) E. coli incubated with 0.005 wt% BRB loaded in shellac NPs coated with 0.008 wt% ODTAB after 2 hours.
Table 1 The cytotoxicity eﬀect of each component on C. reinhardtii,
yeast, and E. coli which represented by (++++: very strong, +++:
strong, ++: medium, and +: weak)
Nanocarrier component
Antimicrobial eﬀect on
C. reinhardtii Yeast E. coli
Shellac NPs stabilised with P407 + + +
Shellac NPs stabilised with P407
and coated ODTAB
+ + +
Free BRB +++ + +++
Shellac NPs loaded with BRB and
stabilised with P407
++ + ++
Shellac NPs loaded with BRB,
stabilised with P407 and coated
with ODTAB
++++ +++ ++++
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View Article Onlinewhereas, ODTAB-coated BRB-loaded shellac NPs showed much
stronger antibacterial eﬀect due to their positive surface charge.
In comparison, a considerable increase in the antibacterial
activity was observed aer incubating E. coli with 0.005 wt%
BRB loaded in ODTAB-coated shellac NPs at the same incuba-
tion time. SEM images of the non-treated (Fig. 12C) and the
treated E. coli cells shown in Fig. 12D–F show how the ODTAB-
coated shellac NPs loaded with BRB have completely covered
the surface of the cells aer 2 hours incubation which amplies
their antimicrobial eﬀect.
In Table 1 we compare qualitatively the eﬀect of shellac NPs
and shellac NPs-encapsulated BRB and the ODTAB-coated
shellac NPs on the studied microorganisms including C. rein-
hardtiimicroalgae, yeast and E. coli (see Fig. 9B, 10B and 11B for
quantitative comparison). The results showed that shellac NPs
did not express signicant antimicrobial eﬀect on these
microorganisms except a very weak eﬀect on the microalgae due
to the presence of P407 which is used to sterically stabilise our
shellac NPs. Free BRB showed moderate antimicrobial eﬀect on
the microalgae and E. coli, but not on yeast. Aer encapsulating
BRB within shellac NPs its eﬀect was reduced due to the inter-
action between the cationic BRB and anionic shellac NPs which
delays the drug release. Besides, the negatively charged shellac
NPs are repelled by the negatively charged microbial cell walls
and this causes the BRB to be released away from the cell
membrane. To overcome this problem, the nanocarriers loaded
with BRB were coated with cationic surfactant ODTAB to changeThis journal is © The Royal Society of Chemistry 2018their charge from negative to positive; this water-insoluble
surfactant has been chosen in order to maintain the stability
of P407-coated shellac NPs. The antimicrobial eﬀect of encap-
sulated BRB coated with ODTAB increased very strongly due to
the electrostatic attraction between the ODTAB-coated encap-
sulated BRB and the cell membranes. Thus, a high concentra-
tion of released BRB is delivered directly on the cell membranes
and kills the cells despite the lower overall concentration of BRB
released in the aqueous media. Shellac NPs loaded with BRB
and coated with ODTAB showed the strongest cytotoxic eﬀect on
the microalgae cells, and slightly less on E. coli and yeast, whichNanoscale Advances
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View Article Onlineis attributed to the larger thickness of their cell membranes.
The ODTAB-coated shellac NPs with encapsulated BRB
expressed cytotoxicity about 20 times higher than the free BRB
on algae and about 5 times higher on yeast and E. coli. On the
other hand, the cytotoxic eﬀect of the shellac NPs coated with
ODTAB but without being loaded with BRB is very weak, i.e. the
ODTAB is not the main contributor for the nanocarrier anti-
microbial action rather than serving to facilitate the nanocarrier
adhesion to the cells and achieve direct delivery.
Conclusions and outlook
We have designed and developed a universal and very eﬃcient
nanocarrier for antimicrobial agents based on shellac, which is
a natural and biodegradable material. We demonstrate the
design and the application of this approach to encapsulate and
deliver berberine chloride (BRB). The nanocarrier was formu-
lated and loaded with antimicrobial agent in two steps: (i) the
rst step involved controlled precipitation of aqueous ammo-
nium shellac salts by a simultaneous pH change from 8 to 5 and
adsorption of surface active polymer (P407) in the presence of
the active antimicrobial component. In this step, the drug-
loaded shellac NPs were formed spontaneously and simulta-
neously coated with a sterically stabilizing polymer, which
allowed them to maintain their stability and ensure long shelf-
life. Stable shellac NPs were produced at pH 5 with a particle
hydrodynamic diameter of 66  5 nm with zeta potential 18 
8 mV. (ii) The second step in the nanocarrier fabrication
involved charge-reversing of the produced shellac NPs by
doping their surface with an insoluble cationic surfactant
(ODTAB), which gave them a positive surface charge in order to
promote the nanocarrier adhesion to the negatively charged cell
membranes of typical bacterial cells. Physical and chemical
parameters such as the eﬀect of diﬀerent concentrations of the
surface active polymer as well as the BRB concentrations were
studied on the size distribution of the produced nanocarriers
and their zeta potential. Optimal nanocarrier stability was ob-
tained at a xed concentration ratio of 0.25 wt% : 0.2 wt% of
shellac : P407. Using 0.01–0.07 wt% concentration range of BRB
with 0.25 wt% shellac at pH 5 to be encapsulated within shellac
NPs we achieved maximum encapsulation eﬃciencies of 60%
for BRB. The interaction between the NPs and the antimicro-
bials was characterized using FTIR and UV-visible techniques.
We studied the release proles of BRB loaded in the developed
shellac nanocarriers and characterised the eﬀect of the BRB-
loading on their size and zeta-potential.
We investigated the importance of the nanocarrier archi-
tecture on the antimicrobial activity of the loaded. We explored
the antimicrobial activity of BRB-loaded shellac nanocarriers on
microalgae, yeast and bacterial cells. Although the free BRB in
aqueous solution had an antimicrobial eﬀect on these micro-
organisms, the non-coated shellac nanocarriers with BRB
showed a reduction in antimicrobial activity due to the elec-
trostatic repulsion between the negatively charged shellac NPs
and the negatively chargedmicrobial cell membranes which did
not allow the encapsulated BRB to be released near the cell wall.
In addition to this, the attraction between the BRB cations andNanoscale Advancesthe shellac matrix of the nanocarriers led to slow BRB release.
However, upon ODTAB functionalization of the BRB-loaded
shellac NPs, their surface charge changed from negative to
positive. We found the optimum conditions where the func-
tionalised shellac nanocarriers become cationic and still
maintained their stability due to steric interactions of the P407
layer. Consequently, the antimicrobial activity of these ODTAB-
coated shellac NPs loaded with BRB showed a very signicant
increase in the antimicrobial eﬀect of BRB compared with the
equivalent overall concentration free BRB in solution. This
eﬀect was due to the strong electrostatic adhesion with the cell
membrane which allowed the antimicrobial agents to be
released directly into the microbial cell. This type of versatile
surface-functionalised shellac nanocarriers can be potentially
applied to boost the action for a range of low-molecular weight
antimicrobial agents. Similar strategy could also be universally
applied for enhancing the action of topical antibiotics and
antifungal agents and could be used across diﬀerent therapies
to ght antimicrobial resistance.
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